Introduction
In the last several years, the efforts aimed at tuberculosis (TB) control and the eradication strategy have been threatened by the emergence of multidrug-resistant (MDR) strains of Mycobacterium tuberculosis. These Multidrug-resistant tuberculosis (MDR-TB) cases cause another complication, regarding worse prognosis, longer duration of treatment, risk of spreading the infection to other people, and a higher economic burden [1] . According to a World Health Organization report in 2014, about 5% of all TB cases globally have been predicted to be MDR-TB cases. The country with the highest number of MDR-TB cases in the world is India with about 30 000 cases, while Indonesia is in the eighth position with approximately 1 800 cases [2] .
Many factors contribute to the occurrence of MDR-TB. Inadequate treatment, failure of treatment, and loss to follow-up are the main factors leading to MDR-TB cases. Other factors include immunity and genetic factors of the host, which in the last several years have been the focus of interest regarding to the occurrence of MDR-TB. Vitamin D level and vitamin D receptor polymorphism have been linked to the occurrence of MDR TB. During tuberculosis infection, macrophage was activated by vitamin D to restrict intracellular growth of Mycobacterium tuberculosis. This effect is achieved through binding to the vitamin D receptor (VDR) in macrophages and cathelicidin synthesis was activated to eliminate M. tuberculosis in phagolysosomes. Polymorphisms in the VDR gene can affect these processes [3, 4] .
Four types of single nucleotide polymorphism (SNP) of the VDR gene, ApaI, BsmI, FokI, and TaqI, have been linked to the occurrence of pulmonary tuberculosis. FokI polymorphisms is a transition C to T (ACG-ATG) at the first of the two potential translation initiation sites in exon 2. If translation starts at the first ATG site (T allele, designated f), VDR protein is synthesized full-length with 427 amino acids. But if the translation starts at the second ATG site (C allele, designated F), the VDR protein lacks the three NH2-terminal amino acids [5] . Transcription of the F allele is 1.7 times more than the f allele [6] , and interaction with transcription factor IIB was more efficient in the F allele, with more potent VDR protein transcription [7] .
The number of studies that link VDR genetic polymorphisms with MDR-TB is still limited. One study in Makassar, Indonesia revealed that there was a role of ApaI and FokI genotype of the VDR gene with MDR-TB [8] . Another study conducted by Rathored et al. stated that there was an association of Ff polymorphism with susceptibility to MDR-TB [9] . A study about the VDR genetic polymorphisms and MDR-TB in Medan, Indonesia is not yet available, but a similar study about these genetic polymorphisms and their role in susceptibility to non-MDR-TB in the Batak ethnic group has been conducted in Medan, Indonesia, showing that there was no role of FokI polymorphism in non-MDR pulmonary TB [10] . The role of vitamin D in non MDR-TB has been widely published. A metaanalysis by Nnoaham and Clarke [11] and Huang et al. [12] showed that there was an association of vitamin D deficiency with the occurrence of pulmonary TB. However, the role of vitamin D in MDR-TB is not widely studied yet. Rathored et al. concluded that vitamin D deficiency might be one of the predisposing factors to the occurrence of MDR-TB [13] . Iftikhar et al. found the same result that the vitamin D level was lower in MDR-TB patients than non-MDR TB patients and healthy controls [14] . In contrast, Herlina et al. found no difference in vitamin D level between MDR-TB patients and healthy household contacts in Indonesia [15] .
The aim of this study is to identify the role of vitamin D receptor FokI polymorphism and the blood level of vitamin D in MDR-TB occurrence in Medan, Indonesia.
Material and methods
This is a case control study with FokI polymorphisms of the vitamin D receptor gene and vitamin D level as independent variables and multidrug-resistant tuberculosis as a dependent variable. Sample size was determined by using a case and control formula. Sample size was 43 subjects for the case group and 56 subjects for the control group. Cases and controls were found by consecutive sampling. This study was approved by the Ethics Committee of the Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
Cases
Cases were pulmonary MDR-TB patients recruited from the MDR-TB polyclinic in Adam Malik Hospital in Medan, Indonesia from April 2016 to October 2016. Adam Malik Hospital is a referral hospital for MDR-TB from several districts. Patients were diagnosed with sputum GeneXpert, and the age range was 18-65 years. Patients who were HIV positive, known to have diabetes mellitus or other severe disease, or taking immunosuppressive drugs and vitamin D were excluded.
Controls
The control group comprised new pulmonary TB cases from several TB services in Medan city, Indonesia, age 18-65 years, having symptoms of pulmonary TB, with positive sputum smear and chest radiography consistent with active disease. Patients who were HIV positive, known to have diabetes mellitus or other severe disease, taking immunosuppressive drugs and vitamin D were excluded.
All subjects were interviewed and informed consent was obtained. An anticoagulated peripheral blood specimen was collected and polymorphism of vitamin D receptor (VDR) gene was analyzed using PCR-RFLP. Vitamin D level was analyzed using the ELISA method.
VDR genotyping
The DNA was extracted (Promega, USA) and stored at minus 20°C. FokI polymorphism of the vitamin D receptor gene was identified by polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP). The primer sequences used in this study were as follows: forward primer: 5′-AGC TGG CCC TGG CAC TGA CTC TGC TCT-3′ and reverse primer: 5′-ATG GAA ACA CCT TGC TTC TTC TCC CTC-3′.
Denaturation at 94°C for 5 min, followed by 35 cycles of PCR at 94°C (30 s), annealing at 61°C and final extension at 72°C for 7 min were the PCR conditions. The amplified PCR products was digested with FokI (Thermo Scientific) restriction enzyme at 37°C for 1 h. Digested products were analyzed using electrophoresis in 2% agarose gel and ethidium bromide stained. The bands were visualized by a gel documentation system.
Depending on the digestion pattern of FokI polymorphism, individuals were scored as ff when homozygous for presence of the FokI site (169 bp and 96 bp), FF when homozygous for absence of the FokI site (265 bp), or Ff in the case of heterozygosity (265 bp, 169 bp and 96 bp). The examination of vitamin D level was performed with an enzyme-linked immunosorbent assay (ELISA) (DIAsource ImmunoAssays S.A., Belgium) Vitamin D serum level was defined as deficient if below 20 ng/ml, insufficient if in the range 20-30 ng/ml, and sufficient if above 30 ng/ml [16] .
Statistical analysis
The c 2 test was used to compare the genotype frequencies of each SNP. The strength of the association between VDR FokI polymorphisms, vitamin D level and MDR-TB risk was evaluated by calculating the odds ratio (OR) with 95% confidence interval (95% CI). The 2-sided exact p-value < 0.05 was considered statistically significant. Data were managed and analyzed using SPSS.
Results
The number of subjects in this study was 43 cases of MDR-TB, and 56 cases of non-MDR TB. The characteristics of subjects in this study are presented in Table I . Table I shows that males were more common than females in both groups. The most common age group was 35-54 years old in MDR-TB and 16-34 years old in non-MDR-TB, while the least common age group was 55-74 years old in both groups. There was no significant difference in gender between the groups, but there was significant association in age distribution.
Based on analysis of FokI polymorphism, there was no significant difference of FokI polymorphism genotype between groups (Table II) . Table III shows that there was no role of FokI polymorphism of the VDR gene in MDR-TB occurrence compared with non-MDR TB. Table IV shows that there was no role of vitamin D level in MDR-TB occurrence compared with non-MDR TB.
Discussion
Studies about VDR gene polymorphism and MDR TB are still limited. One study in Indonesia revealed an association of MDR-TB with ApaI and FokI polymorphisms [8] . Another study by Rathored et al. showed an association between Ff polymorphism and low level of vitamin D with MDR-TB [9] . This study showed that there was no role of FokI polymorphism of the VDR gene in MDR-TB occurrence. This study also did not find a role of vitamin D level in MDR-TB occurrence.
This difference might be due to the difference in population and subjects. The frequency of FokI VDR gene polymorphism in the world is different between ethnic groups and populations. The F allele of VDR gene polymorphism is relatively low in the African population (24%) compared with Caucasian (34%) and Asian (51%) populations [17] .
This difference in results might also be due to the difference in environmental influence such as nutrition intake, smoking and alcohol consumption, which was different from other studies.
Another important reason is that MDR-TB patients in this study were all secondary MDR-TB, patients with prior treatment with anti-tuberculosis drugs. Hence, the occurrence of MDR TB in this study is particularly because of mutation in the microorganism due to inadequate treatment. History of anti-tuberculosis treatment is a strong risk factor to develop MDR-TB. People with prior history of antituberculosis treatment are 10 times more likely to develop MDR-TB compared to those without prior treatment [18] .
Nevertheless, this study still has several limitations. We did not recognize any smoking habit or alcohol consumption in both case and control groups, which could also contribute to MDR-TB occurrence and vitamin D level. Another limitation is the fact that we did not perform sputum culture or a sensitivity test in the control group (new pulmonary TB cases). However, recent data suggested that primary resistance of MDR-TB in new TB cases occurred only in about 4% of all patients [19] . This study also has a difference of age between groups, which could also have influenced the results.
This study identified only one type of polymorphism from several kinds of VDR gene polymorphisms reported. It is possible that other VDR gene polymorphisms could also contribute to the MDR-TB occurrence. In addition, gene-gene interaction [20] and gene-agent interaction could also influence the occurrence of tuberculosis [21] .
This study was conducted in Indonesia, which straddles the equator and is exposed to sunlight throughout the year. A study on healthy woman in Indonesia at the same location where this study was done found that no subject had a sufficient vitamin D level; most of them were deficient or insufficient [22] . This might explain the result of the study by Herlina in Indonesia, who found no difference in vitamin D level between MDR-TB patients and healthy household contacts [15] .
A low level of vitamin D may also be caused by a disturbed cellular pathway of vitamin D synthesis, from vitamin D diffusion in the target cell, vitamin D receptor and formation with RXR (retinoid X receptor), enzymes that are involved in these processes and vitamin D receptor polymorphisms [4] .
Further studies are still needed particularly to identify the smoking history, alcohol consumption, nutritional intake, and occupation in both groups, which may influence the level of vitamin D and the susceptibility to MDR-TB. Another study of polymorphism of another gene is also needed to identify the role of other gene polymorphism in MDR-TB. It is particularly important to identify risk factors for MDR-TB, and hence could lead to a better prevention and treatment strategy of MDR-TB. 
